Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Unnecessary Prolonged Use of Topical Steroid and Antifungal Medications

Batavia, Illinois Survey Completed on 02-20-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to ensure a resident’s medication regimen was free from unnecessary drugs. Review of the physician order sheet showed continuous orders for triamcinolone acetonide 0.1% ointment twice daily for fungal dermatitis starting 9/17/25 with no stop date, and miconazole nitrate 2% cream daily for groin fungus starting 5/27/25 with no stop date. Medication administration records from May 2025 through February 2026 showed both topical medications were administered as ordered for extended periods, with triamcinolone given twice daily for five consecutive months and miconazole given daily for nine consecutive months. During interviews and observations, an LPN reported that the resident’s groin redness was intermittent and related to hygiene, and that he continued to apply both ointments daily even when the skin appeared clear. On observation, the resident’s bilateral groin was clear with no redness, and the resident stated the redness had resolved about a month earlier while staff continued applying both medications. The Infection Preventionist RN confirmed the orders were written as continuous rather than as needed despite the intermittent nature of the condition. The Infectious Disease NP stated that triamcinolone has potential side effects when used long term and that both triamcinolone and miconazole are usually temporary treatments, indicating triamcinolone should be discontinued and miconazole used only as needed. The facility’s own medication administration policy requires staff to contact a prescriber if a medication is believed to be inappropriate, excessive, or associated with potential adverse consequences, which was not done in this case.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙